NDC Package 49230-212-52 Delflex

Dextrose Monohydrate,Sodium Chloride,Sodium Lactate,Calcium Chloride,Magnesium Chloride - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
49230-212-52
Package Description:
2 BAG in 1 CARTON / 5000 mL in 1 BAG
Product Code:
Proprietary Name:
Delflex
Non-Proprietary Name:
Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride
Substance Name:
Calcium Chloride; Dextrose Monohydrate; Magnesium Chloride; Sodium Chloride; Sodium Lactate
Usage Information:
DELFLEX ® peritoneal dialysis solutions are indicated in the treatment of chronic renal failure patients being maintained on peritoneal dialysis when nondialytic medical therapy is judged to be inadequate.
11-Digit NDC Billing Format:
49230021252
Product Type:
Human Prescription Drug
Labeler Name:
Fresenius Medical Care North America
Dosage Form:
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route(s):
  • Intraperitoneal - Administration within the peritoneal cavity.
  • Intraperitoneal - Administration within the peritoneal cavity.
  • Pharmacologic Class(es):
  • Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
  • Calcium - [CS]
  • Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
  • Cations, Divalent - [CS]
  • Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
  • Increased Large Intestinal Motility - [PE] (Physiologic Effect)
  • Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
  • Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
  • Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
  • Osmotic Activity - [MoA] (Mechanism of Action)
  • Osmotic Laxative - [EPC] (Established Pharmacologic Class)
  • Phosphate Binder - [EPC] (Established Pharmacologic Class)
  • Phosphate Chelating Activity - [MoA] (Mechanism of Action)
  • Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
  • Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
  • Calcium - [CS]
  • Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
  • Cations, Divalent - [CS]
  • Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
  • Increased Large Intestinal Motility - [PE] (Physiologic Effect)
  • Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
  • Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
  • Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
  • Osmotic Activity - [MoA] (Mechanism of Action)
  • Osmotic Laxative - [EPC] (Established Pharmacologic Class)
  • Phosphate Binder - [EPC] (Established Pharmacologic Class)
  • Phosphate Chelating Activity - [MoA] (Mechanism of Action)
  • Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
  • Sample Package:
    No
    FDA Application Number:
    NDA020171
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    08-19-1992
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    49230-212-236 BAG in 1 CARTON / 2000 mL in 1 BAG
    49230-212-304 BAG in 1 CARTON / 3000 mL in 1 BAG
    49230-212-324 BAG in 1 CARTON / 3000 mL in 1 BAG
    49230-212-502 BAG in 1 CARTON / 5000 mL in 1 BAG
    49230-212-622 BAG in 1 CARTON / 6000 mL in 1 BAG
    49230-212-925 BAG in 1 CARTON / 2000 mL in 1 BAG
    49230-212-945 BAG in 1 CARTON / 2500 mL in 1 BAG
    49230-212-954 BAG in 1 CARTON / 3000 mL in 1 BAG

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 49230-212-52?

    The NDC Packaged Code 49230-212-52 is assigned to a package of 2 bag in 1 carton / 5000 ml in 1 bag of Delflex, a human prescription drug labeled by Fresenius Medical Care North America. The product's dosage form is solution and is administered via intraperitoneal form.

    Is NDC 49230-212 included in the NDC Directory?

    Yes, Delflex with product code 49230-212 is active and included in the NDC Directory. The product was first marketed by Fresenius Medical Care North America on August 19, 1992 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 49230-212-52?

    The 11-digit format is 49230021252. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-249230-212-525-4-249230-0212-52